Live Discussion with Dr. Mohit Agarwal
Questions doctors asked during the Jivo Masterclass on Diagnosis and Detection of Cancer, taught by Dr. Mohit Agarwal, Principal Director & Unit Head, Medical Oncology, Fortis Hospital, Shalimar Bagh, New Delhi, India, on . Written by Jivo Healthcare from the transcript of the session, drafted with AI assistance and edited by the Jivo team.
Why order a genetic test for a patient who already has cancer? Will it help the prognosis?
Asked by Dr. Oruronana Paul Adugbo
It helps in three ways: it may reveal specific therapies available only for that patient, it tells you whether other family members are at risk, and it tells you whether that individual has a tendency to develop cancer in another part of the body.
Answered by Dr. Mohit Agarwal
Can testing for tumour markers be used as a screening test for cancer in a general patient checkup?
Asked by Moderator
No. Tumour markers are not specific to cancer and can be raised in non-cancerous situations too, so they should not be used as a screening tool. In a patient already diagnosed with cancer, however, they are useful for monitoring the disease.
Answered by Dr. Mohit Agarwal
What is the current management strategy for colorectal cancer?
Asked by Dr. Manal
First, a biopsy to understand what type of cancer it is. Second, a PET-CT scan to determine whether it is stage one, two, three or four. If it is stage one to three, the patient may go for surgery with further treatment based on the report; stage four starts with medical management first.
Answered by Dr. Mohit Agarwal
How can we bring cancer diagnostics down to the local level?
Asked by Dr. Abdul Samad Jihad
Only through education and awareness. If patients know the seven warning signs of cancer, they will talk to their doctor and undertake screening, which brings cancer diagnosis down to the local level and enables earlier treatment.
Answered by Dr. Mohit Agarwal
To prevent cancer death and increase early treatment, what can be done to detect and diagnose cancer?
Asked by Dr. Woo
The same principle applies: go for screening, be aware of the warning signs, and maintain a healthy lifestyle, meaning regular exercise, no tobacco, minimal alcohol and a balanced diet. Doing these things means you will either not develop cancer or you will catch it early.
Answered by Dr. Mohit Agarwal
What are the risks of working in a close environment to chemotherapy?
Asked by Dr. Gabriel Tekka
Chemotherapy, if not handled properly, can be toxic to people nearby. It has to be prepared in a specific mixing unit with proper precautions, and only staff trained in handling and administering chemotherapy should give it.
Answered by Dr. Mohit Agarwal
What are the best treatment options for already metastasised malignant disease?
Asked by Dr. Isaya
It is not a one-size-fits-all approach. It depends on the individual patient, which cancer is present in the body, and which site it has metastasised to. Treatment can be chemotherapy, immunotherapy or targeted therapy depending on exactly what is being treated.
Answered by Dr. Mohit Agarwal
Why do brain tumours relapse so much compared with other tumours?
Asked by Dr. Muri
Brain tumours relapse mainly when they are high-grade tumours or at an advanced stage. The primary modality for brain tumours is surgery, but complete surgical removal of an infiltrating tumour in the brain is nearly impossible, so high-grade tumours are likely to recur. Low-grade tumours that can be completely removed are cured.
Answered by Dr. Mohit Agarwal
A male patient has a cystic mass with solid components draining blood-stained, chocolate-coloured, thick fluid from the left breast, and histology is not yet available. What type of breast cancer is this likely to be, and what is the likely prognosis?
Asked by Dr. William Gataga
Any discharge from a male breast is not normal. It can be an infection, a malignancy, or something arising from the chest wall. The key next step is imaging and a histopathological diagnosis; this could turn out to be breast cancer, which would need immediate treatment.
Answered by Dr. Mohit Agarwal
What are the prognostic factors for breast cancer?
Asked by Dr. Solomon
The major prognostic factors are the patient, the stage of the disease, and the biology of the disease, meaning which receptors are present on the tumour for targeted or hormonal therapy.
Answered by Dr. Mohit Agarwal
If a patient responds to chemotherapy, is there any further need for radiotherapy?
Asked by Moderator
For early breast cancer with lymph node involvement in the armpit, radiotherapy is typically given after chemotherapy to sterilise the local area. Whether radiotherapy is needed depends on the individual patient's stage and disease.
Answered by Dr. Mohit Agarwal
Can chemotherapy and hormonal therapy be combined for the treatment of breast cancer?
Asked by Dr. Solomon
They are not usually given together, because they have been seen to oppose each other. Hormonal therapy can be combined with targeted therapy and immunotherapy, but it is usually not given along with chemotherapy; if both are needed, hormonal therapy is given after the chemotherapy is completed.
Answered by Dr. Mohit Agarwal
In case of relapse after successful chemotherapy, what other modality of treatment can be adopted?
Asked by Moderator
If the relapse is localised to one or two sites after a good amount of time, the patient might be given re-surgery or radiation to that area, along with some medical management depending on the biology of the disease. If the relapse is not local, it is medical management: chemotherapy, targeted therapy or immunotherapy, depending on the receptors present.
Answered by Dr. Mohit Agarwal
What is the best therapy for a patient above 60 years old with advanced breast cancer?
Asked by Moderator
It depends again on the patient's receptor status. It could be chemotherapy with some form of maintenance, targeted therapy if HER2-positive, hormonal therapy if the hormone receptors are positive, or immunotherapy if the patient fits those categories.
Answered by Dr. Mohit Agarwal
You said tumour markers have no role in screening for ovarian cancer. If a patient has ovarian cancer of the smallest size, do tumour markers have a role in diagnosis?
Asked by Dr. Isaya
A tumour marker is a red flag in a patient suspected of having the disease, but it does not clinch the diagnosis. Diagnosis is confirmed only on the basis of a biopsy or complete resection histopathology. Even if a patient has ovarian cancer with some metastasis and a raised CA-125, I cannot directly start treatment: I have to perform a biopsy to confirm the histopathology first.
Answered by Dr. Mohit Agarwal
I have a stage-four leiomyosarcoma patient at the end stage where nutritional approaches aren't working. How can nutrition care be incorporated into cancer management, and should it be at a policy level or a treatment level?
Asked by General Dimma, Ghana
The amount and quality of food consumed matters broadly for cancer prevention: a balanced diet appropriate to the individual's age, height and weight, an ideal body weight and regular exercise support immunity against cancer and other diseases alike. For an advanced case like this, remember that cancer is a catabolic state, meaning the body breaks down more than it builds up, so the patient needs support to keep the muscles maintained: a good protein diet, calcium and vitamin D if deficient, vitamin B1 and folate if deficient, regular meals at regular intervals, less sugar, and complete avoidance of alcohol and tobacco, with protein supplements if the patient is underweight. Nutrition is a core part of every cancer management plan, and a nutritionist is a must in every cancer care team, assessing and treating each patient individually.
Answered by Dr. Mohit Agarwal
Book a Consultation with Dr. Mohit Agarwal
Book on WhatsAppOr message us on WhatsApp: +91 98182 98669